Dr. Stephenson on 2 Years Following the Management of Localized Prostate Cancer

Andrew J. Stephenson, MD
Published: Friday, Jun 02, 2017



Andrew J. Stephenson, MD, director for the Center of Urologic Oncology at the Cleveland Clinic, discusses the significance of a study investigating urinary, bowel, and sexual function at 2 years following the management of localized prostate cancer.

This is the first comparative study among 4 different treatments, explains Stephenson. This gives patients information regarding what to expect over the next 2 years with each treatment option.

According to Stephenson, it is important to balance the cancer control so as not to jeopardize a patient’s curability at the expense of quality of life.



Andrew J. Stephenson, MD, director for the Center of Urologic Oncology at the Cleveland Clinic, discusses the significance of a study investigating urinary, bowel, and sexual function at 2 years following the management of localized prostate cancer.

This is the first comparative study among 4 different treatments, explains Stephenson. This gives patients information regarding what to expect over the next 2 years with each treatment option.

According to Stephenson, it is important to balance the cancer control so as not to jeopardize a patient’s curability at the expense of quality of life.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x